甲与卡巴烯和皮佩拉西林/塔扎巴克坦作为细菌性急性胆结炎的初始治疗方法的比较有效性:一项回顾性研究

Kazuhiro Aoto1, Ryo Inose2, Tadashi Kosaka3

  • 1Department of Pharmacy, University Hospital, Kyoto Prefectural University of Medicine, Kajii-Cho, Kawaramachi-Hirokoji, Kamigyo-Ku, Kyoto, 602-8566, Japan; Laboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, 5 Misasaginakauchicho, Kyoto Yamashina-ku, Kyoto, 607-8414, Japan.

概括

甲 (CMZ) 为治疗由ESBL产生的肠杆菌引起的急性胆道炎提供了一种具有成本效益的替代方案,与卡巴和皮佩拉西林/塔扎巴克坦相比,它可以减少住院时间,但不会影响患者的治疗结果.